Robaxin and Acne - a phase IV clinical study of FDA data

Summary:

Acne is reported as a side effect among people who take Robaxin (methocarbamol), especially for people who are female, 60+ old, also take Xeljanz Xr, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Acne when taking Robaxin. It is created by eHealthMe based on reports of 8,252 people who have side effects when taking Robaxin from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Acne?

Acne (skin problems that cause pimples) is found to be associated with 1,313 drugs and 2,348 conditions by eHealthMe. Check the latest studies of Acne.

On Jul, 21, 2026

8,252 people reported to have side effects when taking Robaxin.
Among them, 21 people (0.25%) have Acne.

Among these 21 people:

What is the gender of people who have Acne when taking Robaxin? *

female: 90.48 %
male: 9.52 %

What is the age of people who have Acne when taking Robaxin? *

What are other drugs people take besides Robaxin? *

What are other side effects people have besides Acne? *

Pain: 9 people, 42.86%
Weakness: 7 people, 33.33%
Depression: 7 people, 33.33%
Fatigue (feeling of tiredness): 7 people, 33.33%
Stress And Anxiety: 7 people, 33.33%
Gait Disturbance: 7 people, 33.33%
Balance Disorder: 6 people, 28.57%
Drug Hypersensitivity: 6 people, 28.57%
Exostosis (formation of new bone on the surface of a bone): 6 people, 28.57%
Fall: 6 people, 28.57%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 47.62%
Depression: 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Type 2 Diabetes: 1 person, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.76%
Dry Eyes (lack of adequate tears): 1 person, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 1 person, 4.76%
Insomnia (sleeplessness): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Acne?

- Check whether Acne is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robaxin:

Robaxin (9,109 reports)

Acne treatments and more:

Acne (179,011 reports)

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acne:

Acne (1,313 drugs)

Browse all the conditions that are associated with Acne:

Acne (2,348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.